Ultraviolet B (UV-B) is a significant environmental factor affecting insect development, survival, and reproduction. DNAJ proteins are molecular chaperones found ubiquitously in insects that are crucial for their adaptation to environmental stresses. This study aimed to elucidate the roles of DNAJ genes in the response of Myzus persicae to UV-B stress. Herein, we identified six DNAJ genes in the aphid M. persicae, a devastating agricultural pest. We analyzed their expression profiles at different stages of development, in different tissues and for various durations of UV-B exposure. The expression levels of MpDNAJC30, MpDNAJC11, MpDNAJC2, and MpDNAJC3 were highest in wingless adults, while MpDNAJC9 and MpDNAJC17 were highest in second- and third-instar nymphs, respectively. Six MpDNAJs had higher expression levels in the epidermis and embryos, and lower levels in the head. Additionally, the expression levels of all genes increased significantly under different durations of UV-B exposure. Knockout of the DNAJ genes using RNA interference caused a significant decline in the survival rate, weight, body length, and body width of M. persicae exposed to UV-B radiation. Our research provides valuable insights into the stress response mechanisms of M. persicae, highlighting the importance of DNAJ genes in mediating their adaptation to UV-B stress.
Rationale: Familial hemophagocytic lymphohistiocytosis (FHL) is a rare fatal autosomal recessively inherited disease and can be divided into five types. The mortality of untreated patients is up to 95% and it can be healed only after immunochemotherapy for disease control and hematopoietic stem cell transplantation. Clinical data of a girl with late-onset and recurrent hemophagocytic lymphohistiocytosis (HLH) was retrospectively analyzed to determine the etiology and potential pathogenic gene.Patient concerns and clinical findings: The proband was a female child patient from a consanguineous marriage family who was 11 years old, and clinically manifested delayed (onset at the age of 4 years and 6 months) and recrudescent HLH. Both of her elder brothers died at the ages of 4 and 5 years, respectively. The patient had a degranulation function defect of CD107a in natural killer (NK) cells, and the degranulation function of cytotoxic T lymphocytes (CTL) obviously declined (ΔMFI: 1.4%, normal ≧2.8%); the degranulation function of NK cells and CTL of her father was also obviously reduced. To identify possible underlying genetic causes, gene mutation analysis was undertaken. A novel homozygous nonsense mutation inSTX11(c.49C>T, p.Q17X) was documented, arising from both her parents.Diagnosis: According to the clinical manifestations and detection results ofSTX11, the diagnosis of FHL-type 4 was confirmed and her parents were heterozygotic carriers.Interventions and outcomes: Good responses to HLH-2004 chemotherapy had been achieved for each onset, and the maximum remission duration (without taking any drug) was 23 months. The patient has been alive for 82 months since the onset, and has stopped taking dexamethasone and etoposide, but is still on oral cyclosporine to maintain the treatment. She has performed HLA matching and now is actively looking for a donor to prepare hematopoietic stem cell transplantation.Conclusions: Relevant gene detections should be implemented at the earliest for young patients from consanguineous marriages and with a family history of HLH so as to provide a basis for etiological diagnosis and radical treatment by hematopoietic stem cell transplantation and provide accurate genetic counseling for family members.